Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Immupharma (IMM) Regulatory News

Date Source Headline
5th May 2011 7:00 am RNS IPP-204106 paper published
26th Apr 2011 4:38 pm RNS Annual Report and Accounts & Notice of AGM
5th Apr 2011 7:00 am RNS Preliminary Results
30th Mar 2011 7:00 am RNS Notification of Preliminary Results
21st Feb 2011 7:00 am RNS Update on progress of Phase I/IIa Clinical Trial
19th Oct 2010 1:08 pm RNS Update on Phase IIa Clinical Trial
11th Oct 2010 2:30 pm RNS Notification of major interests in shares
11th Oct 2010 2:30 pm RNS Additional Listing and Total Voting Rights
30th Sep 2010 7:00 am RNS Interim Results
28th Sep 2010 10:18 am RNS Notification of Interim Results
28th Jun 2010 7:00 am RNS Presentation at the International Congress
23rd Jun 2010 7:40 am RNS Replacement of Development release
23rd Jun 2010 7:00 am RNS Cephalon initiates critical steps in development
17th Jun 2010 12:02 pm RNS Result of AGM
10th Jun 2010 10:55 am RNS Annual Report and Accounts
19th May 2010 7:01 am RNS Initiation Of Phase I/IIA Studies In Cancer
19th May 2010 7:00 am RNS Preliminary Results
8th Apr 2010 9:26 am RNS Best Drug Development Company in Europe Award
5th Jan 2010 3:00 pm RNS Additional Listing
5th Jan 2010 7:00 am RNS ING take 4% stake in ImmuPharma plc
3rd Dec 2009 7:00 am RNS R&D Symposium at the CNRS in Paris
19th Nov 2009 7:00 am RNS Positive Final Lupuzor Trial Results
19th Oct 2009 10:31 am RNS 'Best Technology 2009' Award at the AIM Awards
9th Oct 2009 10:14 am RNS Appointment of Joint Broker
29th Sep 2009 7:00 am RNS Interim Results
21st Sep 2009 9:55 am RNS 8th Annual Bio Investor Forum
17th Sep 2009 7:00 am RNS JMP Healthcare Focus Conference
24th Jul 2009 12:12 pm RNS Result of AGM
23rd Jul 2009 4:17 pm RNS Directors' Dealings
30th Jun 2009 7:00 am RNS Annual Report and Accounts
24th Jun 2009 7:00 am RNS Preliminary Results
17th Jun 2009 7:00 am RNS Piper Jaffray Europe Conference
23rd Mar 2009 7:00 am RNS Directors' Dealings
4th Feb 2009 12:32 pm RNS Share Options
2nd Feb 2009 2:33 pm RNS Cephalon license exercise
30th Jan 2009 7:00 am RNS Successful trial results
22nd Dec 2008 12:00 pm RNS further instalment of grant
25th Nov 2008 7:00 am RNS Option Agreement with Cephalon
12th Nov 2008 7:00 am RNS Grant Award
21st Oct 2008 9:31 am RNS Patents Granted
FTSE 100 Latest
Value8,871.31
Change61.57